Global Single Cell Analysis Market
Marktgröße in Milliarden USD
CAGR :
% 
 Prognosezeitraum |
2024 –2031 |
 Marktgröße (Basisjahr) | USD 4.14 Billion |
 Marktgröße (Prognosejahr) | USD 13.21 Billion |
 CAGR |
% |
| Wichtige Marktteilnehmer |
|
Global Single Cell Analysis Market Segmentation, By Product (Consumables, Instruments), Cell Type (Animal Cells, Microbial Cells, Human Cells), Technique (Flow Cytometry, Next-Generation Sequencing, Polymerase Chain Reaction, Microscopy, Mass Spectrometry, Other Techniques), Application (Research Applications, Medical Applications), End User (Hospitals and Diagnostic Laboratories, Cell Banks and IVF centers, Biotechnology and Biopharmaceutical Companies, Research and Academic Laboratories) – Industry Trends and Forecast to 2031.
Single Cell Analysis Market Analysis
Over the recent years, there has been a surge in cases of various cancers across the world. According to GLOBOCAN, cancer cases would increase to almost 30 million by 2040, up from 19.3 million cases and ten million cancer deaths in 2020. Consequently, the increased prevalence will further lead to growth in cancer research investments and growing biotechnology and biopharmaceutical. Therefore, the market is estimated to show lucrative growth opportunities within the forecasted period.
Single Cell Analysis Market Size
Global single cell analysis market size was valued at USD 4.14 billion in 2023 and is projected to reach USD 13.21 billion by 2031, with a CAGR of 15.60% during the forecast period of 2024 to 2031.
Report Scope and Market Segmentation
|
Attributes |
Single Cell Analysis Key Market Insights |
|
Segmentation |
|
|
Countries Covered |
U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East and Africa. |
|
Key Market Players |
BD (U.S.), Danaher (U.S.), Merck KGAA (Germany), QIAGEN N.V. (Netherlands), Thermo Fisher Scientific Inc., (U.S.), Luminex Corporation (U.S.), 10x Genomics (U.S.), Promega Corporation (U.S.), Illumina, Inc. (U.S.), Bio-Rad Laboratories (U.S.), Fluidigm (U.S.), Agilent Technologies, Inc. (U.S.), Tecan Trading AG (Switzerland), Sartorius AG (Germany), Takara Bio Inc., (Japan), Fluxion Biosciences Inc., (U.S.), Menarini Silicon Biosystems (Italy), bioMérieux (France), Oxford Nanopore Technologies plc. (U.K), Cytek Biosciences (U.S.), Corning Incorporated (U.S.), Apogee Flow Systems Ltd. (U.K), NanoCellect Biomedical (U.S.), Rarecyte Inc (U.S.), On-chip Biotechnologies Co., Ltd. (Japan) |
|
Market Opportunities |
|
Single Cell Analysis Market Definition
Single-cell analysis is the study of genomes, transcriptomics, proteomics, and metabolomics at the single-cell level, and it is used in cancer research and the treatment of a variety of chronic and infectious disorders. It is useful for revealing population, identifying market sub-populations of interest, uncovering unique traits of individual cells, and discovering heterogeneity.
Single Cell Analysis Market Dynamics
This section deals with understanding the market drivers, advantages, opportunities, restraints and challenges. All of this is discussed in detail as below:
Drivers
- Growing Burden Of Cancer Worldwide
The rising prevalence of cancer is the most significant factor driving the growth for this market. Growing factors that lead to cancer are also expected to accelerate the market's overall growth.
- Rapid Economic Growth
The rapid urbanization and digitization, enhanced healthcare infrastructure and growth in awareness are also projected to bolster the growth of the market.
Furthermore, the growing focus on personalized medicine combined with growth in stem cell research are also expected to fuel market growth. Moreover, the rising adoption of single-cell analysis devices also cushions the market's growth within the forecasted period.
Opportunities
- Growing Investments and Advancements
Moreover, the technological advancements in single-cell analysis products coupled with increasing research and development activities across the pharmaceutical and biotechnology industries are estimated to generate lucrative opportunities for the market. The increase in investments and government funds deployed in the field of medical diagnostics along with the advent of technology in single-cell amplification and manipulation techniques resulting in application of high throughput technologies in assays will further offer numerous growth opportunities for the market.
Restraints/Challenges
- High Costs
The cost of the instruments are high so they are not affordable by various research and academic laboratories due to budget constraints, which is expected to obstruct market growth.
- Technical Limitations
Also, various technical limitations are projected to challenge the single cell analysis market in the forecast period of 2024-2031.
This single cell analysis market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the single cell analysis market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Covid-19 Impact on Single Cell Analysis Market
The single cell analysis market was positively impacted by the outbreak of COVID-19. The pandemic's economic and social toll has driven governments around the world to increase funding for vaccine development and production, resulting in a rise in the use of single-cell analysis products for COVID-19 research. Although the imposition various restrictions by the government affected the overall production and sales, but the increased single-cell analysis products demand. To better construct prognostic and diagnostic indicators and establish appropriate therapeutic approaches for patients with severe disease presentation, a better understanding of the host immune response throughout disease progression is critical. The single-cell analysis can help researchers better understand immune cells on a single-cell level and how functional cells contribute to immune protection and pathogenesis, allowing for the development of more effective vaccines and immunotherapies.
Therefore, the increased product demand and ongoing research activities (by exploring the application of the single-cell analysis technique in the SARS-CoV2) during the COVID-19, the market is expected to have good opportunities for growth during the pandemic.
Single Cell Analysis Market Scope
The single cell analysis market is segmented on the basis of product, cell type, technique, application and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Product
- Consumables
- Instruments
On the basis of product, the single cell analysis market is segmented into consumables and instruments. The consumables are sub-segmented into beads, microplates, reagents, assay kits and other consumables. Assay kits further include immunoassays and cell-based assays. The other consumables include culture dishes, flasks, tubes, cuvettes, cryovials, filtration apparatus, petri dishes, inserts and discs. The instruments are sub-segmented into flow cytometers, NGS systems, PCR instruments, spectrophotometers, microscopes, cell counters, HCS systems, microarrays and other instruments.
Cell Type
- Animal Cells
- Microbial Cells
- Human Cells
On the basis of cell type, the single cell analysis market is segmented into animal cells, microbial cells and human cells.
Technique
- Flow Cytometry
- Next-Generation Sequencing
- Polymerase Chain Reaction, Microscopy
- Mass Spectrometry
- Other Techniques
On the basis of technique, the single cell analysis market is segmented into flow cytometry, next-generation sequencing, polymerase chain reaction, microscopy, mass spectrometry and other techniques.
Application
- Research Applications
- Medical Applications
On the basis of application, the single cell analysis market is segmented into research applications and medical applications.
End User
- Hospitals and Diagnostic Laboratories
- Cell Banks and IVF centers
- Biotechnology and Biopharmaceutical Companies
- Research and Academic Laboratories
On the basis of end user, the single cell analysis market is bifurcated into hospitals and diagnostic laboratories, cell banks and IVF centers, biotechnology and biopharmaceutical companies and research and academic laboratories.
Single Cell Analysis Market Regional Analysis
The single cell analysis market is analyzed and market size insights and trends are provided by country, product, cell type, technique, application and end user as referenced above.
The countries covered in the single cell analysis market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the single cell analysis market because of the developed healthcare infrastructure, rising expenditure on personalized medicine and increasing prevalence of cancer within the region.
Asia-Pacific is expected to witness significant growth during the forecast period of 2022 to 2029 due to the rapidly developing healthcare infrastructure and increasing disposable income within the region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
The single cell analysis market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for single cell analysis market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the single cell analysis market. The data is available for historic period 2010-2020.
Single Cell Analysis Market Share
The single cell analysis market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to single cell analysis market.
Single Cell Analysis Market Leaders Operating in the Market Are:
- BD (U.S.)
- Danaher (U.S.)
- Merck KGAA (Germany)
- QIAGEN N.V. (Netherlands)
- Thermo Fisher Scientific Inc., (U.S.)
- Luminex Corporation (U.S.)
- 10x Genomics (U.S.)
- Promega Corporation (U.S.)
- Illumina, Inc. (U.S.)
- Bio-Rad Laboratories (U.S.)
- Fluidigm (U.S.)
- Agilent Technologies, Inc. (U.S.)
- Tecan Trading AG (Switzerland)
- Sartorius AG (Germany)
- Takara Bio Inc., (Japan)
- Fluxion Biosciences Inc., (U.S.)
- Menarini Silicon Biosystems (Italy)
- bioMérieux (France)
- Oxford Nanopore Technologies plc. (U.K)
- Cytek Biosciences (U.S.)
- Corning Incorporated (U.S.)
- Apogee Flow Systems Ltd. (U.K)
- NanoCellect Biomedical (U.S.)
- Rarecyte Inc (U.S.)
- On-chip Biotechnologies Co., Ltd. (Japan)
Latest Developments in Single Cell Analysis Market
- In October 2020, BD, a leading global medical technology company, received US FDA's 510 (K) clearance for its BD FACSLyric Flow Cytometer with Newly Integrated BD FACSDuet Sample Preparation System. The new integrated system allows clinical laboratories to fully automate the sample to answer process, decreasing mistakes and reducing the number of manual user contacts necessary to execute BD FACSLyricTM Flow Cytometer assays
SKU-
Erhalten Sie Online-Zugriff auf den Bericht zur weltweit ersten Market Intelligence Cloud
- Interaktives Datenanalyse-Dashboard
- Unternehmensanalyse-Dashboard für Chancen mit hohem Wachstumspotenzial
- Zugriff für Research-Analysten für Anpassungen und Abfragen
- Konkurrenzanalyse mit interaktivem Dashboard
- Aktuelle Nachrichten, Updates und Trendanalyse
- Nutzen Sie die Leistungsfähigkeit der Benchmark-Analyse für eine umfassende Konkurrenzverfolgung
Forschungsmethodik
Die Datenerfassung und Basisjahresanalyse werden mithilfe von Datenerfassungsmodulen mit großen Stichprobengrößen durchgeführt. Die Phase umfasst das Erhalten von Marktinformationen oder verwandten Daten aus verschiedenen Quellen und Strategien. Sie umfasst die Prüfung und Planung aller aus der Vergangenheit im Voraus erfassten Daten. Sie umfasst auch die Prüfung von Informationsinkonsistenzen, die in verschiedenen Informationsquellen auftreten. Die Marktdaten werden mithilfe von marktstatistischen und kohärenten Modellen analysiert und geschätzt. Darüber hinaus sind Marktanteilsanalyse und Schlüsseltrendanalyse die wichtigsten Erfolgsfaktoren im Marktbericht. Um mehr zu erfahren, fordern Sie bitte einen Analystenanruf an oder geben Sie Ihre Anfrage ein.
Die wichtigste Forschungsmethodik, die vom DBMR-Forschungsteam verwendet wird, ist die Datentriangulation, die Data Mining, die Analyse der Auswirkungen von Datenvariablen auf den Markt und die primäre (Branchenexperten-)Validierung umfasst. Zu den Datenmodellen gehören ein Lieferantenpositionierungsraster, eine Marktzeitlinienanalyse, ein Marktüberblick und -leitfaden, ein Firmenpositionierungsraster, eine Patentanalyse, eine Preisanalyse, eine Firmenmarktanteilsanalyse, Messstandards, eine globale versus eine regionale und Lieferantenanteilsanalyse. Um mehr über die Forschungsmethodik zu erfahren, senden Sie eine Anfrage an unsere Branchenexperten.
Anpassung möglich
Data Bridge Market Research ist ein führendes Unternehmen in der fortgeschrittenen formativen Forschung. Wir sind stolz darauf, unseren bestehenden und neuen Kunden Daten und Analysen zu bieten, die zu ihren Zielen passen. Der Bericht kann angepasst werden, um Preistrendanalysen von Zielmarken, Marktverständnis für zusätzliche Länder (fordern Sie die Länderliste an), Daten zu klinischen Studienergebnissen, Literaturübersicht, Analysen des Marktes für aufgearbeitete Produkte und Produktbasis einzuschließen. Marktanalysen von Zielkonkurrenten können von technologiebasierten Analysen bis hin zu Marktportfoliostrategien analysiert werden. Wir können so viele Wettbewerber hinzufügen, wie Sie Daten in dem von Ihnen gewünschten Format und Datenstil benötigen. Unser Analystenteam kann Ihnen auch Daten in groben Excel-Rohdateien und Pivot-Tabellen (Fact Book) bereitstellen oder Sie bei der Erstellung von Präsentationen aus den im Bericht verfügbaren Datensätzen unterstützen.
